Sven Berger

Title: Sven Berger: Innovator in Phage Display Technology

Introduction

Sven Berger is a notable inventor based in Poisy, France. He has made significant contributions to the field of biotechnology, particularly in the development of phage display technology. His innovative work has led to the creation of a unique patent that enhances the capabilities of phage display vectors.

Latest Patents

Sven Berger holds a patent for a minimized phage display vector. This invention comprises at least a cloning cassette, a phage display cassette, and a bacterial cassette. The cloning cassette includes a nucleic acid sequence encoding a polypeptide that corresponds to the intra-domain loop of a constant domain of an antibody. This technology is instrumental in producing libraries of phages, each expressing a binding protein that can be screened for its ability to bind to specific partners.

Career Highlights

Sven Berger is currently associated with Pierre Fabre Medicament, where he applies his expertise in biotechnology. His work focuses on advancing the applications of phage display technology in various therapeutic contexts. His innovative approach has positioned him as a key player in the field.

Collaborations

Sven collaborates with talented professionals such as Peter Lowe and Alexandra Jouhanneaud. These partnerships enhance the research and development efforts within his team, fostering an environment of innovation and creativity.

Conclusion

Sven Berger's contributions to phage display technology exemplify the impact of innovative thinking in biotechnology. His patent and ongoing work at Pierre Fabre Medicament highlight the importance of collaboration and creativity in advancing scientific knowledge.